VEGFA and neoplasm: In particular, TEV released from tumour-educated platelets stimulate MAPK p42/44 and AKT, increase the expression of MMP1, MMP9, VEGF and cyclin D2 [277] and induce EMT by activating TGFβ1 and NF-κB signalling [278].